Download | < Back |
06 Oct 2017 | |
Submission of Quarterly statement of Investor Complaints under Regulation 13(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 | |
View all announcements for TORRENT PHARMACEUTICALS LTD. | Source: BSE India |